-
-
Overview
-
Clinic Signification:
1.The BCR/ABL fusion gene is a marker of CML and is also present in 30% of adult ALL, about 10% of child ALL, and a small amount of AML. In ALL, it means that the prognosis is extremely poor.
2.Guiding medication, used to guide the use of targeted therapy Gleevec, treatment options and drug efficacy evaluation.Please contact us at for specific academic pricing.
-
- Properties
- Applications
-
Overview